[go: up one dir, main page]

WO1997039029A3 - An antigenic epitope of the a determinant of hepatitis b surface antigen and uses thereof - Google Patents

An antigenic epitope of the a determinant of hepatitis b surface antigen and uses thereof Download PDF

Info

Publication number
WO1997039029A3
WO1997039029A3 PCT/US1997/006732 US9706732W WO9739029A3 WO 1997039029 A3 WO1997039029 A3 WO 1997039029A3 US 9706732 W US9706732 W US 9706732W WO 9739029 A3 WO9739029 A3 WO 9739029A3
Authority
WO
WIPO (PCT)
Prior art keywords
hepatitis
surface antigen
antigenic epitope
determinant
peptide
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/US1997/006732
Other languages
French (fr)
Other versions
WO1997039029A2 (en
Inventor
Dominique P Bridon
Xiaoxing Qiu
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Abbott Laboratories
Original Assignee
Abbott Laboratories
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Laboratories filed Critical Abbott Laboratories
Priority to JP09537434A priority Critical patent/JP2000514643A/en
Priority to EP97921323A priority patent/EP0906337A2/en
Publication of WO1997039029A2 publication Critical patent/WO1997039029A2/en
Anticipated expiration legal-status Critical
Publication of WO1997039029A3 publication Critical patent/WO1997039029A3/en
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/08—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses
    • C07K16/081—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from viruses from DNA viruses
    • C07K16/082—Hepadnaviridae, e.g. hepatitis B virus
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/576—Immunoassay; Biospecific binding assay; Materials therefor for hepatitis
    • G01N33/5761—Hepatitis B
    • G01N33/5764—Hepatitis B surface antigen
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2730/00—Reverse transcribing DNA viruses
    • C12N2730/00011—Details
    • C12N2730/10011—Hepadnaviridae
    • C12N2730/10111—Orthohepadnavirus, e.g. hepatitis B virus
    • C12N2730/10122—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Communicable Diseases (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Physics & Mathematics (AREA)
  • General Physics & Mathematics (AREA)
  • Pathology (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Analytical Chemistry (AREA)
  • Food Science & Technology (AREA)
  • Microbiology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)

Abstract

The subject invention relates to a peptide sequence corresponding to amino acid residues (117 to 128) of hepatitis B surface antigen and uses thereof. In particular, the peptide is an antigenic epitope and may therefore be used, for example, as a diagnostic reagent or in the production of a vaccine. Furthermore, the present invention also relates to a C(K/R)TC motif present within the peptide as well as to other peptides containing this motif.
PCT/US1997/006732 1996-04-18 1997-04-18 An antigenic epitope of the a determinant of hepatitis b surface antigen and uses thereof Ceased WO1997039029A2 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
JP09537434A JP2000514643A (en) 1996-04-18 1997-04-18 Antigenic epitope of a-determinant of hepatitis B surface antigen and its use
EP97921323A EP0906337A2 (en) 1996-04-18 1997-04-18 AN ANTIGENIC EPITOPE OF THE u A /u DETERMINANT OF HEPATITIS B SURFACE ANTIGEN AND USES THEREOF

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US63542896A 1996-04-18 1996-04-18
US08/635,428 1996-04-18

Publications (2)

Publication Number Publication Date
WO1997039029A2 WO1997039029A2 (en) 1997-10-23
WO1997039029A3 true WO1997039029A3 (en) 2001-06-28

Family

ID=24547753

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/US1997/006732 Ceased WO1997039029A2 (en) 1996-04-18 1997-04-18 An antigenic epitope of the a determinant of hepatitis b surface antigen and uses thereof

Country Status (4)

Country Link
EP (1) EP0906337A2 (en)
JP (1) JP2000514643A (en)
CA (1) CA2251904A1 (en)
WO (1) WO1997039029A2 (en)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0919568A1 (en) * 1997-12-01 1999-06-02 Sorin Diagnostics S.r.l. Escape mutant of the surface antigen of hepatitis B virus
EP1111388A1 (en) * 1999-12-23 2001-06-27 Universiteit Gent Interaction between CD14 and HBV components
ES2488849T3 (en) * 2004-06-07 2014-08-29 Novartis Vaccines And Diagnostics, Inc. Rabbit monoclonal antibodies to hepatitis B surface antigens and methods of use thereof
JP4948783B2 (en) * 2005-05-18 2012-06-06 シスメックス株式会社 Anti-HBs monoclonal antibody
EP2860188B1 (en) * 2012-06-11 2020-10-21 Xiamen University Polypeptides and antibodies for treating hbv infection and related diseases
WO2017059878A1 (en) 2015-10-07 2017-04-13 Humabs Biomed Sa Antibodies that potently neutralize hepatitis b virus and uses thereof
WO2018149315A1 (en) 2017-02-17 2018-08-23 厦门大学 Peptide carrier for displaying target polypeptide and use thereof
CN113544148B (en) 2018-12-19 2024-04-05 胡默波斯生物医学公司 Antibodies for neutralizing hepatitis B virus and uses thereof
EA202191736A1 (en) 2018-12-20 2021-10-01 Вир Байотекнолоджи, Инк. HBV COMBINATION THERAPY
BR112022024996A2 (en) * 2020-06-08 2022-12-27 Hoffmann La Roche ANTIBODIES, NUCLEIC ACID, HOST CELL, METHOD FOR PRODUCING AN ANTIBODY, PHARMACEUTICAL COMPOSITION, THERAPEUTIC AGENT, USE OF THE ANTIBODY, AND METHOD FOR TREATING AN INDIVIDUAL WITH HEPATITIS B

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0155146A2 (en) * 1984-03-09 1985-09-18 Scripps Clinic And Research Foundation Synthetic hepatitis B virus vaccine including both T cell and B cell determinants
JPH045300A (en) * 1990-04-20 1992-01-09 Tetsuo Nakamura Viral hepatitis type b vaccine and antibody specific to hbs antigen
WO1995016704A1 (en) * 1993-12-16 1995-06-22 Smithkline Beecham Biologicals S.A. Hepatitis b virus peptides

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP0155146A2 (en) * 1984-03-09 1985-09-18 Scripps Clinic And Research Foundation Synthetic hepatitis B virus vaccine including both T cell and B cell determinants
JPH045300A (en) * 1990-04-20 1992-01-09 Tetsuo Nakamura Viral hepatitis type b vaccine and antibody specific to hbs antigen
WO1995016704A1 (en) * 1993-12-16 1995-06-22 Smithkline Beecham Biologicals S.A. Hepatitis b virus peptides

Non-Patent Citations (6)

* Cited by examiner, † Cited by third party
Title
CHEMICAL ABSTRACTS, vol. 113, no. 9, 27 August 1990, Columbus, Ohio, US; abstract no. 76023, MUNEKATA, EISUKE ET AL: "Epitope mapping in the protein of hepatitis B-virus" XP002044689 *
DATABASE WPI Section Ch Week 9208, Derwent World Patents Index; Class B04, AN 92-060743, XP002044690 *
FERNANDEZ-DE-COSSIO, MARIA E. ET AL: "Murine monoclonal antibodies specific for the HBsAg a determinant", BIOTECNOL. APL. (1995), 12(2), 89-90 CODEN: BTAPEP;ISSN: 0864-4551, 1995, XP002044687 *
H. OHNUMA ET AL.: "Synthetic Oligopeptides Bearing a Common or Subtypic Determinant of Hepatitis B Surface Antigen", JOURNAL OF IMMUNOLOGY, vol. 145, no. 7, 1 October 1990 (1990-10-01), BALTIMORE US, pages 2265 - 2271, XP002044688 *
PEPT. CHEM. (1990), VOLUME DATE 1989, 27TH, 281-4 CODEN: PECHDP;ISSN: 0388-3698, 1990 *
QIU, XIAOXING ET AL: "Identification and characterization of a C(K/R)TC motif as a common epitope present in all subtypes of hepatitis B surface antigen", J. IMMUNOL. (1996), 156(9), 3350-6 CODEN: JOIMA3;ISSN: 0022-1767, 1 May 1996 (1996-05-01), XP002044686 *

Also Published As

Publication number Publication date
EP0906337A2 (en) 1999-04-07
WO1997039029A2 (en) 1997-10-23
CA2251904A1 (en) 1997-10-23
JP2000514643A (en) 2000-11-07

Similar Documents

Publication Publication Date Title
CA2025598A1 (en) Chimaeric hepadnavirus core antigen proteins
AU9052891A (en) Proteins with changed epitopes and methods for the production thereof
WO1995029193A3 (en) Melanoma antigens
CA2078694A1 (en) Hepatitis b vaccine
KR910016343A (en) Serum Reactive Epitopes of Human Papillomavirus (HPV) 16 Protein
WO1995012677A3 (en) Immunodominant human t-cell epitopes of hepatitis c virus
ES2068907T3 (en) NUCLEOTIDE SEQUENCES CODING A PROTEIN WITH UREASIC ACTIVITY.
DE68928130D1 (en) Synthetic peptides derived from HIV-GP120-env protein and their application
IL88224A0 (en) Peptides,artificial antigens and immunoassay kits
AU5376201A (en) Methods and compositions for impairing multiplication of hiv-1
CA2175567A1 (en) Chimeric proteins comprising borrelia polypeptides: uses therefor
BR9810907A (en) Monoclonal and polyclonal antibodies, peptide capable of generating an antibody, immunogenic agent, nucleotide sequence, pharmaceutical composition, use of at least one antibody, diagnostic kit, and process for preparing an immunogenic agent
AU5533490A (en) Synthetic (pseudomonas) (aeruginosa) pilin peptide and related vaccines and diagnostics
WO1997039029A3 (en) An antigenic epitope of the a determinant of hepatitis b surface antigen and uses thereof
DE69737413D1 (en) Bakterioferritin aus helicobacter pylori
DE3380629D1 (en) Region-specific determinants for vitamin k dependent bone protein
NZ592340A (en) A method for making a virus vaccine compising Replikin peptides
CA2084386A1 (en) Hiv antigen
NZ335633A (en) Production of recombinant H. pylori polypeptides for treatment and diagnosis of H. pylori related diseases
JPS5657753A (en) Novel glucagon fragment, and its use
EP0177814A3 (en) Peptide antibodies and their use in detecting oncogene products
IE883545L (en) Peptide structures, immunogens containing them and their uses in the control of fertility
WO1990012807A3 (en) Purified, highly specific antibodies against gene products including retinoblastoma and method
CA2085191A1 (en) Vaccines based on modified type 1 bovine herpesviruses
AU1464488A (en) Human rhinovirus peptides

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): CA JP

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE

121 Ep: the epo has been informed by wipo that ep was designated in this application
DFPE Request for preliminary examination filed prior to expiration of 19th month from priority date (pct application filed before 20040101)
ENP Entry into the national phase

Ref document number: 2251904

Country of ref document: CA

Ref country code: CA

Ref document number: 2251904

Kind code of ref document: A

Format of ref document f/p: F

WWE Wipo information: entry into national phase

Ref document number: 1997921323

Country of ref document: EP

WWP Wipo information: published in national office

Ref document number: 1997921323

Country of ref document: EP

WWW Wipo information: withdrawn in national office

Ref document number: 1997921323

Country of ref document: EP

AK Designated states

Kind code of ref document: A3

Designated state(s): CA JP

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): AT BE CH DE DK ES FI FR GB GR IE IT LU MC NL PT SE